Karen Keeshan

13PUBLICATIONS
40CO-AUTHORS
Haematological tumoursPsychosocial aspects of childbirth and perinatal mental healthInfant and child healthHaematologyNanoscale characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 13, 2026
Inducing TRIB2-targeted protein degradation to reverse chemoresistance in acute myeloid leukaemia.

Evie Rigby, Francesca Fasanella Masci, Akshara Narayanan

|Jan 01, 2026
Fetal defense against leukemia: a developmental shield.

Karen Keeshan

|Nov 11, 2024
Paediatric bone marrow mesenchymal stem cells support acute myeloid leukaemia cell survival and enhance chemoresistance via contact-independent mechanism.

Alison Laing, Ahmed Elmarghany, Arwa A Alghaith

|Feb 14, 2022
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness.

Chiara Pirillo, Flora Birch, Floriane S Tissot

|Jul 02, 2021
Structure vs. Function of TRIB1-Myeloid Neoplasms and Beyond.

Hamish D McMillan, Karen Keeshan, Anita K Dunbier

|Jan 12, 2021
BRD4-mediated repression of p53 is a target for combination therapy in AML.

Anne-Louise Latif, Ashley Newcombe, Sha Li

Pageof 3

Frequent Collaborators

1 joint publications

Daniel M Foulkes

1 joint publications

Wayland Yeung

1 joint publications

Safal Shrestha

1 joint publications

Claire E Eyers